Verastem Inc has a consensus price target of $23.61, established from looking at the 26 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., RBC Capital, and BTIG on March 19, 2024, March 15, 2024, and November 21, 2023. With an average price target of $25.5 between HC Wainwright & Co., RBC Capital, and BTIG, there's an implied 177.17% upside for Verastem Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/19/2024 | VSTM | Buy Now | Verastem | $9.20 | 90.22% | HC Wainwright & Co. | Sean Lee | → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | VSTM | Buy Now | Verastem | $9.20 | 247.83% | RBC Capital | Gregory Renza | → $32 | Reiterates | Outperform → Outperform | Get Alert |
11/21/2023 | VSTM | Buy Now | Verastem | $9.20 | 193.48% | BTIG | Justin Zelin | → $27 | Assumes | → Buy | Get Alert |
11/15/2023 | VSTM | Buy Now | Verastem | $9.20 | 269.57% | Truist Securities | Srikripa Devarakonda | $39 → $34 | Maintains | Buy | Get Alert |
09/29/2023 | VSTM | Buy Now | Verastem | $9.20 | 128.26% | B. Riley Securities | Kalpit Patel | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
09/27/2023 | VSTM | Buy Now | Verastem | $9.20 | 128.26% | B. Riley Securities | Kalpit Patel | → $21 | Initiates | → Buy | Get Alert |
08/29/2023 | VSTM | Buy Now | Verastem | $9.20 | 291.3% | Mizuho | Mara Goldstein | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | VSTM | Buy Now | Verastem | $9.20 | 247.83% | RBC Capital | Gregory Renza | $34 → $32 | Maintains | Outperform | Get Alert |
07/11/2023 | VSTM | Buy Now | Verastem | $9.20 | 323.91% | Truist Securities | Srikripa Devarakonda | $60 → $39 | Maintains | Buy | Get Alert |
07/06/2023 | VSTM | Buy Now | Verastem | $9.20 | 269.57% | Cantor Fitzgerald | Alethia Young | → $34 | Reiterates | Overweight → Overweight | Get Alert |
07/03/2023 | VSTM | Buy Now | Verastem | $9.20 | 269.57% | RBC Capital | Gregory Renza | $36 → $34 | Maintains | Outperform | Get Alert |
06/27/2023 | VSTM | Buy Now | Verastem | $9.20 | 552.17% | Truist Securities | Srikripa Devarakonda | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | VSTM | Buy Now | Verastem | $9.20 | 552.17% | Truist Securities | Srikripa Devarakonda | → $60 | Reiterates | Buy → Buy | Get Alert |
06/15/2023 | VSTM | Buy Now | Verastem | $9.20 | 291.3% | Mizuho | Mara Goldstein | $24 → $36 | Upgrade | Neutral → Buy | Get Alert |
05/10/2023 | VSTM | Buy Now | Verastem | $9.20 | -78.26% | HC Wainwright & Co. | Sean Lee | $36 → $24 | Maintains | Buy | Get Alert |
03/30/2023 | VSTM | Buy Now | Verastem | $9.20 | -78.26% | Mizuho | Mara Goldstein | → $24 | Initiates | → Neutral | Get Alert |
03/15/2023 | VSTM | Buy Now | Verastem | $9.20 | -67.39% | RBC Capital | Gregory Renza | → $36 | Reiterates | → Outperform | Get Alert |
03/15/2023 | VSTM | Buy Now | Verastem | $9.20 | -67.39% | HC Wainwright & Co. | Sean Lee | → $36 | Reiterates | → Buy | Get Alert |
11/07/2022 | VSTM | Buy Now | Verastem | $9.20 | -67.39% | HC Wainwright & Co. | Sean Lee | $60 → $36 | Maintains | Buy | Get Alert |
The latest price target for Verastem (NASDAQ: VSTM) was reported by HC Wainwright & Co. on March 19, 2024. The analyst firm set a price target for $17.50 expecting VSTM to rise to within 12 months (a possible 90.22% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Verastem (NASDAQ: VSTM) was provided by HC Wainwright & Co., and Verastem reiterated their buy rating.
The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.
There is no last downgrade for Verastem.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on March 19, 2024 so you should expect the next rating to be made available sometime around March 19, 2025.
While ratings are subjective and will change, the latest Verastem (VSTM) rating was a reiterated with a price target of $0.00 to $17.50. The current price Verastem (VSTM) is trading at is $9.20, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.